PHARMACY

Teva intros generic Entocort EC

BY David Salazar
NORTH WALES, Penn. — Teva Pharmaceuticals on Thursday announced the introduction of its generic of Entocort EC (budesonide) enteric coated 3-mg capsules. The drug is indicated to treat mild to moderate active and in remission Crohn’s disease in the ileum and/or ascending colon. 
 
“Our customers count on Teva for a continuous supply of new generic products,” Teva SVP and general manager U.S. generics Maureen Cavanaugh said. “With the launch of budesonide capsules (enteric coated), we add another quality product to our broad line of affordable generic pharmaceuticals.”
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Pfizer completes Anacor acquisition

BY David Salazar
NEW YORK — Pfizer on Friday announced that it had completed its acquisition of Anacor Pharmaceuticals. Under the terms of the acquisition, every outstanding share of Anacor’s common stock has been converted into the right to receive $99.25 in net cash. 
 
“Now that Anacor is part of Pfizer, we can accelerate our shared commitment to help patients with inflammatory disease, an area of high unmet medical need,” Pfizer group president innovative health Albert Bourla said. “We believe that Pfizer is in a position to quickly capitalize on the benefits offered by the combination with Anacor, including the potential for a near-term U.S. product launch and subsequent commercialization of crisaborole, a differentiated asset with compelling clinical data. If approved, crisaborole has the potential to be an important first-line treatment option for patients with mild-to-moderate atopic dermatitis and the physicians who treat them.”
 
Pfizer said it does not expect the deal to affect its current 2016 financial guidance, and still expects it to be dilutive to earnings per share in 2017, with accretion kicking in in 2018 and increasing in the following years. 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

NCPA announces dates for ‘Re-Engineering Your Pharmacy Practice Boot Camp’

BY Michael Johnsen

 

ALEXANDRIA, Va. – The National Community Pharmacists Association on Thursday announced a new educational program to empower community pharmacy owners to re-engineer their practices to participate in clinical service opportunities. The Re-Engineering Your Pharmacy Practice Boot Camp, to be held Aug. 12-13 in Alexandria, Va., will feature peer-to-peer learning and best practices from five speakers who have successfully implemented expanded clinical services in community pharmacies.

"The health care market is evolving to a value-based model, and it's more important than ever for community pharmacies to evolve their business model today to be more successful tomorrow," stated Bradley Arthur, NCPA president and co-owner of Black Rock Pharmacy and Brighton-Eggert Pharmacy in Buffalo, N.Y. "I am excited about this new program from NCPA because it will help many pharmacy owners get started with the process of expanding their pharmacy's clinical services and filling gaps in care in their local communities. I encourage pharmacy owners and managers to join us in August for this energetic and in-depth look at how to re-invent your business."

The day-and-a-half-long program will provide 7.5 hours of continuing education credits and cover topics such as optimizing the dispensing process; streamlining workflow and engaging staff; financial considerations for building an expanded services portfolio; how to use technology to document clinical encounters; and developing a brand to launch a new suite of services.

Featured speakers at the program include David D. Pope, chief of innovation at Creative Pharmacist; Joe Moose, co-owner of Moose Pharmacy in Concord, N.C.; Tripp Logan, part owner of L & S Pharmacy, Medical Arts Pharmacy and New Madrid Pharmacy in Missouri; Elaine Ladd, owner of Ladd Family Pharmacy in Boise, Idaho; and Ashley Branham, director of clinical services at Moose Pharmacy.

Boot Camp attendees will also have opportunities for ongoing interaction with the speakers after the program is over through a series of conference calls so they can continue to get advice and feedback while implementing changes in their pharmacy.

The Re-Engineering Your Pharmacy Practice Boot Camp is sponsored by Amneal, IMS Health, and PioneerRx, with additional sponsorship opportunities available, NCPA noted.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?